Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-19

FDA Approved: METOPROLOL SUCCINATE — Original Application (Oryza Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved Oryza Pharmaceuticals' generic metoprolol succinate product, an extended-release beta-blocker used to treat hypertension, angina, and heart fai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metoprolol succinate (METOPROLOL SUCCINATE)

Snippet

ORIG AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)